Head of CRO

Jovana joined GC CRO in December 2021, bringing 15 years of experience in clinical operations, business development, and key account management. She has worked with top organizations such as IQVIA, Parexel, George Clinical, and Medtronic. Her expertise covers a wide range of therapeutic areas, including oncology, radiopharmaceuticals, GMOs, gastroenterology, cardiology, coronary and structural heart devices, infectious diseases, and dermatology. Jovana has successfully led clinical trials from First-in-Human to post-marketing phases and has designed tailored data solutions to support post-marketing sales activities.

Director of Physics and Imaging Services

Dr Boon Quan Lee, PhD is the Director of Physics and Imaging Services at GC Clinical CRO heading the in-house imaging  Research Organisation (IRO) team. He has over 12 years in nuclear physics and radiopharmaceutical fields. He has led the design and execution of central imaging and dosimetry strategy for diagnostic and therapeutic radiopharmaceuticals in 15+ clinical trials across Ph0-III since 2021. He has supported data interpretation for CSR and biodistribution report writing, as well as regulatory submission post database lock for Sponsors.

He has been a key driver behind the creation of IRO which has evolved into a specialised team of physicists, imaging specialists and physicians offering boutique and innovative imaging and dosimetry solutions to address the unmet needs for growing number of local and international radiopharmaceutical companies. Dr. Lee has also co-authored over 30 publications in peer-reviewed journals. 

Director, Data Operations

Patrick has worked in data-management roles of increasing seniority since 2002 with pharmaceutical and biotech companies including Eli Lily, Boehringer, ICON, Aptiv Solutions, Trium Analysis Online and Novotech in Switzerland, UK, Germany and Australia. He is experienced with Veeva, Viedoc, Medidata RAVE, Oracle Inform, Castor and other RTSM/CTMS tools.

Senior Director, Clinical Operations & Safety

Azmira brings over 15 years of diverse experience in both R&D and the Commercial sectors of the pharmaceutical industry. Within R&D, she has led and managed clinical trial delivery across multiple therapeutic areas and phases, ensuring successful outcomes from early-phase studies through to Phase IV. In the Commercial sector, Azmira has supported market entry of pharmaceutical products and developed tailored data insights solutions to help companies navigate the competitive ANZ market landscape.

Her therapeutic expertise spans key areas such as Oncology, Ophthalmology, Respiratory, Endocrinology, Rare Diseases and Nephrology, with a comprehensive understanding from Phase I to Phase IV studies.

At GenesisCare CRO, Azmira oversees the Clinical Operations & Safety teams, providing leadership in project management and client engagement, ensuring the highest standards of operational excellence and patient safety.

Associate Director, Project Management

Joseph has over 15 years of clinical research experience, with a primary focus on oncology across Phases I-IV. His therapeutic expertise includes oncology, metabolic diseases, infectious diseases, immunology, nephrology, respiratory conditions, rare diseases, and radiopharmaceutical clinical trial management. He has successfully led multi-country trials in Australia, New Zealand, Korea, Taiwan, Hong Kong, Thailand, and China.

Joseph joined GC CRO in January 2023 and currently leads a team of project managers and project assistants, overseeing various imaging and therapeutic trials and medical device studies in APAC, USA and South America.

Head of Quality Assurance

Robin brings over 30 years of experience in senior-level quality management roles within the Clinical Research and Pharmaceutical Life Sciences industries. As the Head of Quality Assurance for the CRO at GenesisCare, Robin is responsible for overseeing the design, implementation, and continuous improvement of the Quality Management System (QMS) to ensure compliance with GxP standards and regulatory requirements.

Before joining GenesisCare, Robin served as the Director of Quality at Nucleus Network, an organisation operating three Phase 1 Clinical Research facilities across Australia and the US. During his 14-year tenure, Robin played a pivotal role in developing and refining their QMS, successfully managing multiple Sponsor/CRO audits and regulatory inspections, including those from the FDA and EMA. He also has a rich background in Good Manufacturing Practice (GMP) through his 13 years at CSL Limited, where he began his career in various quality-related positions.

Robin is dedicated to applying Quality by Design (QbD) principles, ensuring that quality is built into every aspect of operations from the outset. He believes in leveraging technology to drive efficiency, improve data integrity, and enhance compliance in GxP-regulated environments. Under his leadership, the Quality Assurance function is seen not just as a compliance requirement but as a strategic partner in improving operational performance and achieving regulatory success.

Research Strategy Proposal Developer

Krystyn joined GenesisCare CRO in December 2021, bringing 17 years of expertise in business development, strategic proposal creation, and budget management for both global and local studies. Prior to GenesisCare, she spent 15 years at IQVIA. With a strong foundation in nursing and a parallel career in clinical research spanning 27 years, Krystyn has extensive experience across all therapeutic areas and phases. Over the past decade, she has specialized in the early phase landscape for ANZ. Her skills in designing strategies and budgets are underpinned by her robust healthcare background.